NO993029L - Polypeptider fra familien "Basic-Helix-Loop-Helix" bHLH, og de tilsvarende nukleinsyresekvenser - Google Patents

Polypeptider fra familien "Basic-Helix-Loop-Helix" bHLH, og de tilsvarende nukleinsyresekvenser

Info

Publication number
NO993029L
NO993029L NO993029A NO993029A NO993029L NO 993029 L NO993029 L NO 993029L NO 993029 A NO993029 A NO 993029A NO 993029 A NO993029 A NO 993029A NO 993029 L NO993029 L NO 993029L
Authority
NO
Norway
Prior art keywords
helix
polypeptides
loop
basic
nucleic acid
Prior art date
Application number
NO993029A
Other languages
English (en)
Norwegian (no)
Other versions
NO993029D0 (no
Inventor
Christine Icard-Liepkalns
Jaques Mallet
Philippe Ravassard
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO993029D0 publication Critical patent/NO993029D0/no
Publication of NO993029L publication Critical patent/NO993029L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/028—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a herpesvirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO993029A 1996-12-19 1999-06-18 Polypeptider fra familien "Basic-Helix-Loop-Helix" bHLH, og de tilsvarende nukleinsyresekvenser NO993029L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615651A FR2757524B1 (fr) 1996-12-19 1996-12-19 Polypeptides de la famille bhlh, sequences d'acides nucleiques correspondantes
PCT/FR1997/002368 WO1998027206A2 (fr) 1996-12-19 1997-12-19 Polypeptides de la famille 'basic helix-loop-helix' bhlh, sequences d'acides nucleiques correspondantes

Publications (2)

Publication Number Publication Date
NO993029D0 NO993029D0 (no) 1999-06-18
NO993029L true NO993029L (no) 1999-08-16

Family

ID=9498862

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993029A NO993029L (no) 1996-12-19 1999-06-18 Polypeptider fra familien "Basic-Helix-Loop-Helix" bHLH, og de tilsvarende nukleinsyresekvenser

Country Status (15)

Country Link
US (1) US6998474B1 (fr)
EP (1) EP0946724A2 (fr)
JP (1) JP2001510464A (fr)
KR (1) KR20000057698A (fr)
AU (1) AU732438B2 (fr)
BR (1) BR9713968A (fr)
CA (1) CA2275454A1 (fr)
CZ (1) CZ219499A3 (fr)
FR (1) FR2757524B1 (fr)
HU (1) HU224305B1 (fr)
IL (1) IL130302A0 (fr)
NO (1) NO993029L (fr)
SK (1) SK81899A3 (fr)
WO (1) WO1998027206A2 (fr)
ZA (1) ZA9711401B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP495598A0 (en) 1998-07-30 1998-08-20 Walter And Eliza Hall Institute Of Medical Research, The A novel regulatory molecule and genetic sequences encoding same
DE60034877T2 (de) * 1999-04-06 2008-01-17 The Regents Of The University Of California, Oakland MENSCHLICHE, FüR NEUROGENIN 3 KODIERENDE NUKLEOTIDSEQUENZEN
EP1354951B1 (fr) * 2000-12-27 2008-06-04 Sumitomo Chemical Company, Limited Methode d'examen de la capacite a controler la plasticite des cellules nerveuses
US20150315607A1 (en) * 2014-01-15 2015-11-05 Academia Sinica Mutated nucleotide molecule, and transformed plant cells and plants comprising the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695995A (en) 1994-05-06 1997-12-09 Fred Hutchinson Cancer Research Center Neurogenic differentiation (neurod) genes
EP0759938A4 (fr) * 1994-05-06 1999-10-27 Hutchinson Fred Cancer Res Proteines et genes de differentiation neurogene (neuro d)
US6566496B1 (en) * 1996-09-27 2003-05-20 California Institute Of Technology Neurogenin

Also Published As

Publication number Publication date
IL130302A0 (en) 2000-06-01
BR9713968A (pt) 2000-04-11
WO1998027206A2 (fr) 1998-06-25
JP2001510464A (ja) 2001-07-31
AU732438B2 (en) 2001-04-26
HUP0001184A3 (en) 2002-01-28
WO1998027206A3 (fr) 1998-10-01
FR2757524A1 (fr) 1998-06-26
HU224305B1 (hu) 2005-07-28
EP0946724A2 (fr) 1999-10-06
FR2757524B1 (fr) 1999-01-29
ZA9711401B (en) 1998-06-25
CA2275454A1 (fr) 1998-06-25
HUP0001184A2 (hu) 2000-08-28
AU5667398A (en) 1998-07-15
US6998474B1 (en) 2006-02-14
SK81899A3 (en) 2000-05-16
CZ219499A3 (cs) 1999-10-13
KR20000057698A (ko) 2000-09-25
NO993029D0 (no) 1999-06-18

Similar Documents

Publication Publication Date Title
ID16224A (id) Bikunin manusia
DK0782966T3 (da) Transportør
FI964423L (fi) DNA-sekvenssit
NO985680L (no) Peptidderivater
EP0645622A3 (fr) Analyseur des bases de l'ADN.
NO983849L (no) Peptidderivater
EP1117779A4 (fr) PROTEINE $i(MORAXELLA CATARRHALIS), SEQUENCE D'ACIDE NUCLEIQUE ET UTILISATIONS DE CELLES-CI
EP0956025A4 (fr) Methode d'immunosuppression
DE69717671D1 (de) Transportvorrichtung
HUP0000493A3 (en) Nematode-inducible regulatory dna sequences
NO993029L (no) Polypeptider fra familien "Basic-Helix-Loop-Helix" bHLH, og de tilsvarende nukleinsyresekvenser
IL123098A0 (en) Placental protein 13
TR199701666A3 (tr) Sismanliga karsi proteinler
TR199501328A2 (tr) Alzheimer peptidi.
BR9709521A (pt) "3-Cianoaril-pirazóis"
AU2161699A (en) Peptides and nucleic acids derived from (eisenia foetida) and the use thereof
DE69724736D1 (de) Prozessablaufsteuerung
GB9623431D0 (en) Transporter
ZA971900B (en) Modified proteins
DE69730411D1 (de) Metastasen induzierende dna's
ATA43793A (de) Dna aus tolypocladium niveum
ZA973709B (en) Proteins.
GB9707599D0 (en) Proteins
GB9614293D0 (en) Modified proteins
GB9818810D0 (en) Transporter protein

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application